Literature DB >> 11824946

Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.

Carol A Hitchon1, Carol L Danning, Gabor G Illei, Hani S El-Gabalawy, Dimitrios T Boumpas.   

Abstract

OBJECTIVE: Matrix metalloproteinases (MMP), especially the gelatinases (MMP2, MMP9), have been implicated in several features of inflammatory arthritis including angiogenesis and bone erosions. We examined the expression and activity of the gelatinases and their regulators in psoriatic skin and synovium using tissue immunohistochemistry and a sensitive tissue based zymographic technique.
METHODS: Lesional and perilesional skin biopsies and synovial samples obtained by closed needle biopsy from 15 patients with erosive psoriatic arthritis (PsA) were analyzed by immunohistochemistry for the expression of the gelatinases and their regulators, tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1, TIMP-2) and membrane type metalloproteinases (MTI-MMP. MT2-MMP), using immunohistochemistry. Synovial tissue from 8 patients with erosive rheumatoid arthritis (RA) was used as a comparison. MMP tissue expression was quantified by 2 blinded independent observers. Immunohistochemical data are reported as the mean percentage positive cells per total nucleated cells in 10 high power fields +/- SD. Functional activity of the gelatinases was measured using a sensitive tissue based zymography technique and corrected for protein content. Zymography data are presented as ng/mg +/- SE.
RESULTS: MMP expression was greater in the synovial lining layer (LL) than in the synovial sublining layer (SL) in both PsA and RA tissue for most MMP except collagenase I (MMPI), which was equally distributed between the LL and SL. Expression of MMP or their regulators did not differ between PsA synovial membrane (SM) and RA SM in LL. Moreover, although latent gelatinase A (MMP2) staining in PsA SM was equivalent to RA SM, increased gelatinase A activity was found in PsA SM over RA SM using zymography L82.4 (SD 62.8) vs 10.1 (SD 1.7); p = 0.02]. Compared to PsA SM, lesional skin had lower levels of MT1-MMP (MMP14) (1.4 +/- 1.7 vs 15.7 +/- 8.4; p = 0.009) and MT2-MMP (MMP15) (12.1 +/- 8.7 vs 21.6 +/- 9.9; p = 0.001).
CONCLUSION: We characterized the expression and activity of gelatinases in PsA and demonstrate that gelatinase activity in SM of PsA patients with erosive disease is comparable to if not greater than that in RA synovium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11824946

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.

Authors:  Dafna D Gladman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets.

Authors:  Bertalan Mesko; Szilard Poliska; Andrea Szegedi; Zoltan Szekanecz; Karoly Palatka; Maria Papp; Laszlo Nagy
Journal:  BMC Med Genomics       Date:  2010-05-05       Impact factor: 3.063

3.  Expression analysis of matrix metalloproteinase-9 in epithelialized and nonepithelialized apical periodontitis lesions.

Authors:  Everdan Carneiro; Renato Menezes; Gustavo Pompermaier Garlet; Roberto Brandão Garcia; Clóvis Monteiro Bramante; Rita Figueira; Mari Sogayar; José Mauro Granjeiro
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-10-16

4.  MMP-2, TNF-α and NLRP1 polymorphisms in Chinese patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  Rongbin Sun; Yong Huang; Hui Zhang; Ruiping Liu
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

5.  Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis.

Authors:  Tajvur Saber; Douglas J Veale; Emese Balogh; Jennifer McCormick; Sinead NicAnUltaigh; Mary Connolly; Ursula Fearon
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

6.  Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.

Authors:  Paola Cordiali-Fei; Elisabetta Trento; Giovanna D'Agosto; Valentina Bordignon; Anna Mussi; Marco Ardigò; Antonio Mastroianni; Antonella Vento; Francesco Solivetti; Enzo Berardesca; Fabrizio Ensoli
Journal:  J Autoimmune Dis       Date:  2006-10-05

7.  A Case of Granuloma Annulare Associated with Secukinumab Use.

Authors:  Lauren Bonomo; Sara Ghoneim; Jacob Levitt
Journal:  Case Rep Dermatol Med       Date:  2017-05-22

8.  Hierarchical functional nanoparticles boost osteoarthritis therapy by utilizing joint-resident mesenchymal stem cells.

Authors:  Yao Lu; Jieli Chen; Lihua Li; Yumei Cao; Yang Zhao; Xiaoyu Nie; Changhai Ding
Journal:  J Nanobiotechnology       Date:  2022-02-19       Impact factor: 10.435

9.  Differences in Osteoimmunological Biomarkers Predictive of Psoriatic Arthritis among a Large Italian Cohort of Psoriatic Patients.

Authors:  Marco Diani; Silvia Perego; Veronica Sansoni; Lucrezia Bertino; Marta Gomarasca; Martina Faraldi; Paolo Daniele Maria Pigatto; Giovanni Damiani; Giuseppe Banfi; Gianfranco Altomare; Giovanni Lombardi
Journal:  Int J Mol Sci       Date:  2019-11-10       Impact factor: 5.923

10.  Defining the Protease and Protease Inhibitor (P/PI) Proteomes of Healthy and Diseased Human Skin by Modified Systematic Review.

Authors:  Callum Stewart-McGuinness; Christopher I Platt; Matiss Ozols; Brian Goh; Tamara W Griffiths; Michael J Sherratt
Journal:  Biomolecules       Date:  2022-03-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.